SUMMARY Vitamin D metabolism was investigated in 10 patients with cirrhosis. Mean plasma 25 hydroxycholecalciferol (25 OHD) concentration in alcoholic cirrhosis was lower than in controls but the difference was not significant. In three patients restudied after the summer, plasma 25 OHD had risen. In contrast to the finding in normal subjects, the half-life of intravenously administered 3H cholecalciferol was short in cirrhotics and showed no correlation with plasma 25 OHD. Furthermore, the appearance of 3H 25 OHD from 3H cholecalciferol was reduced compared to the control group four hours after injection. Increased rate of metabolism of cholecalciferol and deficient production of 25 OHD contribute to vitamin D deficiency in liver disease.
SUMMARY Vitamin D metabolism was investigated in 10 patients with cirrhosis. Mean plasma 25 hydroxycholecalciferol (25 OHD) concentration in alcoholic cirrhosis was lower than in controls but the difference was not significant. In three patients restudied after the summer, plasma 25 OHD had risen. In contrast to the finding in normal subjects, the half-life of intravenously administered 3H cholecalciferol was short in cirrhotics and showed no correlation with plasma 25 OHD. Furthermore, the appearance of 3H 25 OHD from 3H cholecalciferol was reduced compared to the control group four hours after injection. Increased rate of metabolism of cholecalciferol and deficient production of 25 OHD contribute to vitamin D deficiency in liver disease.
The association of osteomalacia and cirrhosis has been described (Atkinson et al., 1956 ). Vitamin D is hydroxylated in the liver to 25 OHD, the main circulating metabolite. Superimposed liver disease in experimental animals with rickets has been shown to increase the amount of vitamin D required to heal the rickets (Heymann, 1938) . Recently, low concencentrations of plasma 25 OHD have been reported in many types of cirrhosis, including cirrhosis due to alcoholism (Hepner et al., 1976; Long et al., 1976 (Dann, 1978) . Plasma 25 OHCC was measured by a competitive proteinbinding assay (Edelstein et al., 1974) . Calcium absorption was measured by a forearm counting technique (Chalmers et al., 1973) after seven days on a 400 mg (10 mmol) calcium diet.
Vitamin D3 half-life, and 25 OHD production were measured after the injection of 2-5 ,uC la2a (n) 3H cholecalciferol (2-10 C/mmol, Radiochemical Centre, Amersham) in absolute alcohol. Blood was sampled at four, eight, 12, 24, and 48 hours and plasma extracted by the method of Bligh and Dyer (1959) . The chloroform extract was evaporated on a rotary evaporator and the cholecalciferol and 25 OHD separated by thin layer chromatography. The radioactivity from each fraction was counted in a Packard 2425 liquid scintillation counter. 3H Cholecalciferol half-life was calculated from a semilog plot of 3HD3 dpm/ml of plasma against time of the values from four to 48 hours.
Statistical analysis was performed using standard parametric tests.
Results
The plasma 25 OHD in the eight alcoholic cirrhotics was 8-7 ± 3.99 ng/mI (mean ± SD). In the two cryptogenic cirrhotics 25 OHD levels were 12-6 and 15-6 ng/ml. Plasma 25 OHD from a normal population studied at the same time of year (winter) was 290 10-4 ± 3-8 ng/ml. The 25 OHD level in the alcoholic cirrhotics was thus lower than in the normal population but failed to achieve a significant degree of difference. Response to ultra-violet light was assessed by reinvestigating four alcoholic cirrhotics in the late summer. There was a considerable rise of plasma 25 OHD in three patients (Table) . Dietary intake was assessed in eight patients. Calcium intake was 911 ± 301 mg/24 h (22-8 ± 7-5 mmol/24 h) and the vitamin D intake was 4'4 ± 4 9 ,Lg/24 h (11 ± 12-3 nmol/24 h). Dietary intake of vitamin D did not correlate with plasma 25 OHD.
Calcium absorption was within normal limits (35-72 %). Three patients had a raised serum bilirubin (39 3, 47-9, 88-9 ,umol/l-that is, 2-3, 2-8, 5-2 mg/dl respectively) and all 10 patients had normal serum calcium and phosphate. Twenty-four hour urinary calcium was low in all patients (3-25 ± 112 mmol/24 h-that is, 130-1 ± 44-8 mg/24 h, normal range 5-10 mmol/24 h) while on a 1000 mg (25 mmol) calcium diet.
iPTH was raised in only one case. Bone biopsy revealed no evidence of osteomalacia or hyperparathyroidism. Vitamin D-binding protein level in the cirrhotics was 298 ± 72 jug/ml (normal range 300-550 ,ug/ml).
Vitamin D-binding protein correlated with serum albumin (r = 0-735, p < 0-02). Vitamin D half-life was short in the cirrhotic patients (Fig. 1) . In three patients no 3H cholecalciferol could be detected in plasma at 48 hours. Vitamin D half-life may be influenced by the state of vitamin D nutrition (Mawer et al., 1971) . We, therefore, compared the vitamin D half-life with the prevailing plasma 25 OHD level (Fig. 1) . Controls showed a significant correlation (r = 0-78, p < 0-01).
Although the cirrhotic patients appeared to cluster around the projected control regression line; they did not, as a population, show a significant correla- (Fig. 2 . Controls r = 0-7, p < 0-02, cirrhotics r = 0-75, p < 0-01). However the slopes of the two regression lines differed significantly (p < 0-02), the cirrhotic groups showing a reduction in the appearance of 3H 25 OHD in plasma when compared with controls. No significant difference was found at eight, 12, or 24 hours after injection of 3H cholecalciferol and the majority of counts at these times were as 25 OHD in both groups.
Discussion
Low levels of plasma 25 OHD have been reported in larger series of alcoholic cirrhotics (Hepner et al., 1976; Long et al., 1976) . The alcoholic cirrhotics in our series had lower values than the controls, but this did not reach a significant level. All our controls and cirrhotics were studied in winter when a difference may not be so apparent. The dietary intake of vitamin D in our Caucasian cirrhotics was adequate and showed no correlation with plasma 25 OHD level, in contrast to the situation found in an immigrant population (Hunt et al., 1976) . In view of the rise of plasma 25 OHD at the end of summer, ultra-violet light may be more important in maintaining plasma 25 OHD in cirrhotics without biliary obstruction. It is noteworthy that patient 1 (Table) showed a considerable rise in plasma 25 OHD by the late summer in spite of a serum bilirubin of 47 9 ,tmol/l (2-8 mg/dl).
Vitamin D and 25 OHD are transported in plasma on a binding protein (DBP) (Haddad and Walgate, 1976) . Levels in cirrhotics were low and correlated with serum albumin; this may reflect impaired liver function. However, it seems unlikely that the low levels of DBP are the cause of low 25 OHD, as the remaining DBP has a considerable reserve of binding capacity; in normal persons DBP is 2-3 % saturated (Haddad and Walgate, 1976) .
We found an abnormally rapid disappearance of 3H cholecalciferol in cirrhosis in contrast with the findings of Avioli et al. (1967) . No correlation existed between 3H cholecalciferol half-life and prevailing level of plasma 25 OHD. Moreover, 3H cholecalciferol half-life remained short in spite of a rise of plasma 25 OHD in late summer. We found a reduced appearance of 3H 25 OHD in plasma at four hours in cirrhosis. This accords with the finding of an impaired rise in plasma 25 OHD 24 hours after the parenteral administration of 120 ,ug vitamin D (Hepner et al., 1976) . In hepatectomised rats in which the appearance of 25 OHD in plasma six hours after the intravenous administration of 3H cholecalciferol was considerably reduced, the removal of 3H cholecalciferol from plasma was slow (Olson et al., 1976) . On the other hand, in the cirrhotic patients a reduced appearance of 3H 25 OHD in plasma was associated with a short cholecalciferol half-life.
It is not clear whether the vitamin D was disappearing into liver or into other tissues. Extrahepatic tissues appear to remove vitamin D only slowly from plasma in hepatectomised rats (Olson et al., 1976) , suggesting that the rapid disappearance of 3H cholecalciferol in cirrhosis may be due to increased uptake by liver. If this is the major route of removal it seems likely to involve increased metabolism via pathways other than 25 hydroxylation.
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